Past Events

Join us for Solve at MIT 2023, May 4-6 on MIT Campus, along with 400 social impact leaders to get inspired, build partnerships, tackle global challenges in real-time, and celebrate progress.

Register: https://solve-mit-edu.ezproxyberklee.flo.org/events/solve-at-mit-2023/custom/public-plenaryLearn more: https://solve-mit-edu.ezproxyberklee.flo.org/events/solve-at-mit-2023

LinkedIn: https://www.linkedin.com/posts/solvemit_solveatmit-activity-7049844743387705344-R0IH

Twitter: https://twitter.com/SolveMIT/status/1644079035134234635

SOLUTIONS with/in/sight: Algorithm and

Views exploring the use of machine learning tools to improve

lung cancer detection and treatment

Join us for an exploration of the reimagined Center for Clinical and Translational Research (CCTR) on Tuesday, May 30, 2023. The CCTR will hold an Open House to showcase the newly renovated facility and its capabilities. Come join us for fun interactive activities (think yo-yo, think ping-pong) in the CCTR’s HealthLab and Motion Capture Suite.

Registration is open for the upcoming Conference on Health, Inference, and Learning (CHIL) 2023, taking place from June 22 - 24, 2023 at the Broad Institute and MIT CSAIL in Cambridge, Massachusetts, USA. 

21^st Annual Cancer Research Symposium hosted by MIT's Koch Institute for Integrative Cancer Research

The Catalyst program, which is part of MIT linQ, fosters the development of enabling technologies to address unmet medical needs. Catalyst is appropriate for those with an interest and a willingness to spend time in research, innovation, and health.

The Healthy ML Group at MIT is hosting a seminar series at the Stata Center this Fall!

Human spaceflight started more than 60 years ago, initiating research on the effects of spaceflight on the human body. Yet, what happens to the brain during a space mission has long been an uncharted domain. 

Come and learn how nanomedicine can help revolutionize medicine—this is the key annual event for researchers developing next-generation delivery vehicles; targeted, responsive, biodegradable nanomaterials for diagnosis and therapy. 

MIT Medical Director Dr. Cecilia Stuopis, M.D., leads a panel discussing biases that patients of color continue to experience in healthcare.